3 Results for "

LRA

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "LRA" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-100522
CAS No.: 1955550-51-2
Purity:  ≥98.0%
Target:  

Atg4 Autophagy

Research Areas:  

Cancer

FMK 9a is an autophagin-1 inhibitor with IC50 values of 80 and 73 μM in FRET and LRA assay.
loading...
    loading...
Cat. No.: HY-119490
CAS No.: 2109805-83-4
Research Areas:  

Infection

UMB-136 is a bromodomain inhibitor. UMB-136 is a promising latency-reversing agent (LRA) for HIV-1 eradication. UMB-136 reactivates HIV-1 in multiple cell models. UMB-136 enhances HIV-1 transcription and increases viral production through the release of P-TEFb .
loading...
    loading...
Cat. No.: HY-180525
Target:  

Influenza Virus

Research Areas:  

Infection

PB2-IN-2 is an orally active PB2 inhibitor with RNA-dependent RNA Polymerase (RNP) IC50 = 0.2 nM, LRA (Ligand Receptor Assay) EC50 = 0.8 nM, Cytopathic Effect (CPE) EC50 = 0.1 nM. PB2-IN-2 exhibits broad-spectrum, nanomolar antiviral potency against a panel of influenza A strains (including H1N1pdm09, Lyon/1337/2007/H1N1, Tex12-Like/H3N2, PR/8/34/H1N1, WSN/1933/H1N1, rPR8(H1N1)/H7N9 with EC50 = 1.5, 3.6, 3.7, 13.8, 2.9 and 9.8 nM and all the CC50 values > 2 μM. PB2-IN-2 possesses an excellent pharmacokinetic profile and metabolic stability. PB2-IN-2 can be used for anti-influenza research .
loading...
    loading...